NEU neuren pharmaceuticals limited

Ann: Q4 2021 quarterly activity and cash flow report, page-35

  1. 169 Posts.
    lightbulb Created with Sketch. 163
    Whilst the proposition of partnerships are entertaining and quite lucrative, I'm actually very interested if Neuren were to be more ambitious and look to do things in house. I'm sure it would be lots of work, but hey, why give away the pie if NEU can do it?

    It would require us to attract high calibre talent, and put in place all the necessary infrastructure and probably a longer timeframe, but to go alone and commercialise NNZ-2591 in all indications would be highly rewarding.

    Who knows perhaps it could be that the TROF result was not only company making in the sense of derisking, partnering and so on, but the foundation of being a full fledged company that specialises in the neurology space?

    Interesting times!

    GLTAH
    Last edited by CrispyPork777: 21/02/22
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.08
Change
0.230(1.79%)
Mkt cap ! $1.635B
Open High Low Value Volume
$13.15 $13.37 $12.92 $4.928M 375.6K

Buyers (Bids)

No. Vol. Price($)
17 199 $13.08
 

Sellers (Offers)

Price($) Vol. No.
$13.09 1322 7
View Market Depth
Last trade - 13.23pm 18/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.